METTL3 and hepatocellular carcinoma: Depletion of METTL3 under hypoxia significantly enhances sorafenib-resistant of HCC by decreasing the stability of FOXO3, and overexpression of FOXO3 restores m6A-dependent sorafenib sensitivity 167.